PREVENT Trial Shows Warfarin Therapy Reduces Risk Of Blood Clots
This article was originally published in The Gray Sheet
Executive Summary
St. Jude Medical looks to benefit from a recent study demonstrating that long-term, low-intensity anticoagulant warfarin therapy can reduce the risk of recurrent life-threatening blood clots by two-thirds